These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32671623)

  • 1. Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors.
    Feitosa JADS; das Chagas PF; de Sousa GR; Queiroz RGP; Cruzeiro GAV; Tone LG; Borges KS; Valera ET
    Mol Biol Rep; 2020 Aug; 47(8):6439-6443. PubMed ID: 32671623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
    J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil.
    Custodio G; Taques GR; Figueiredo BC; Gugelmin ES; Oliveira Figueiredo MM; Watanabe F; Pontarolo R; Lalli E; Torres LF
    PLoS One; 2011 Mar; 6(3):e18015. PubMed ID: 21445348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
    Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
    Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
    Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
    BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation.
    Figueiredo BC; Sandrini R; Zambetti GP; Pereira RM; Cheng C; Liu W; Lacerda L; Pianovski MA; Michalkiewicz E; Jenkins J; Rodriguez-Galindo C; Mastellaro MJ; Vianna S; Watanabe F; Sandrini F; Arram SB; Boffetta P; Ribeiro RC
    J Med Genet; 2006 Jan; 43(1):91-6. PubMed ID: 16033918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.
    Formiga MNDC; de Andrade KC; Kowalski LP; Achatz MI
    JAMA Oncol; 2017 Oct; 3(10):1400-1402. PubMed ID: 28114597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.
    Custódio G; Parise GA; Kiesel Filho N; Komechen H; Sabbaga CC; Rosati R; Grisa L; Parise IZ; Pianovski MA; Fiori CM; Ledesma JA; Barbosa JR; Figueiredo FR; Sade ER; Ibañez H; Arram SB; Stinghen ST; Mengarelli LR; Figueiredo MM; Carvalho DC; Avilla SG; Woiski TD; Poncio LC; Lima GF; Pontarolo R; Lalli E; Zhou Y; Zambetti GP; Ribeiro RC; Figueiredo BC
    J Clin Oncol; 2013 Jul; 31(20):2619-26. PubMed ID: 23733769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma.
    de Almeida Magalhães T; Borges KS; de Sousa GR; Brandalise SR; Seidinger AL; Scrideli CA; Oba-Shinjo SM; Yunes JA; Tone LG
    Neurol Sci; 2020 Mar; 41(3):691-694. PubMed ID: 31728854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
    Mastellaro MJ; Seidinger AL; Kang G; Abrahão R; Miranda ECM; Pounds SB; Cardinalli IA; Aguiar SS; Figueiredo BC; Rodriguez-Galindo C; Brandalise SR; Yunes JA; Barros-Filho AA; Ribeiro RC
    Cancer; 2017 Aug; 123(16):3150-3158. PubMed ID: 28387921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
    Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.
    Assumpção JG; Seidinger AL; Mastellaro MJ; Ribeiro RC; Zambetti GP; Ganti R; Srivastava K; Shurtleff S; Pei D; Zeferino LC; Dufloth RM; Brandalise SR; Yunes JA
    BMC Cancer; 2008 Dec; 8():357. PubMed ID: 19046423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.
    Mastellaro MJ; Ribeiro RC; Oliveira-Filho AG; Seidinger AL; Cardinalli IA; Miranda ECM; Aguiar SS; Brandalise SR; Yunes JA; Barros-Filho AA
    J Pediatr (Rio J); 2018; 94(4):432-439. PubMed ID: 28864397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation.
    Rossbach HC; Baschinsky D; Wynn T; Obzut D; Sutcliffe M; Tebbi C
    Pediatr Blood Cancer; 2008 Mar; 50(3):681-3. PubMed ID: 17427234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of an inherited cancer predisposition syndrome associated with the germ line TP53 R337H mutation in Paraguay.
    Legal EF; Ascurra M; Custódio G; Ayala HL; Monteiro M; Vega C; Fernández-Nestosa MJ; Vega S; Sade ER; Coelho IM; Ribeiro EM; Cavalli IJ; Figueiredo BC
    Cancer Epidemiol; 2015 Apr; 39(2):166-9. PubMed ID: 25736369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil.
    Matzenbacher Bittar C; de Araújo Rocha YM; Vieira IA; Rosset C; Andreis TF; Sartor ITS; Artigalás O; Netto CBO; Alemar B; Macedo GS; Ashton-Prolla P
    PLoS One; 2021; 16(9):e0251639. PubMed ID: 34529667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the
    Sandoval RL; Masotti C; de Macedo MP; Ribeiro MFSA; Leite ACR; Meireles SI; Bovolin RM; Santini FC; Munhoz RR; Jardim DLF; Katz A; Camargo AA; Fernandes GDS; Achatz MI
    JCO Glob Oncol; 2021 Jul; 7():1141-1150. PubMed ID: 34270331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Common Germline
    Jeffers JR; Pinto EM; Rehg JE; Clay MR; Wang J; Neale G; Heath RJ; Lozano G; Lalli E; Figueiredo BC; Pappo AS; Rodriguez-Galindo C; Chen W; Pounds S; Ribeiro RC; Zambetti GP
    Cancer Res; 2021 May; 81(9):2442-2456. PubMed ID: 33637564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
    Giacomazzi J; Graudenz MS; Osorio CA; Koehler-Santos P; Palmero EI; Zagonel-Oliveira M; Michelli RA; Scapulatempo Neto C; Fernandes GC; Achatz MI; Martel-Planche G; Soares FA; Caleffi M; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    PLoS One; 2014; 9(6):e99893. PubMed ID: 24936644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.